397 results on '"Shukla, Sachet A."'
Search Results
2. Germline variants associated with toxicity to immune checkpoint blockade
3. Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect
4. ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
5. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer
6. HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
7. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study
8. Genetic mechanisms of immune evasion in colorectal cancer
9. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
10. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
11. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia
12. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
13. Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit
14. Enriched Signalling Pathways in Venetoclax-Relapsed Chronic Lymphocytic Leukemia (CLL) Cells and Targeting Using a Protac-Based Bcl-2/Bcl-Xl Degrader
15. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
16. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
17. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
18. A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens
19. Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).
20. Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms
21. Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma
22. Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma
23. Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironment
24. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
25. The Somatic Genomic Landscape of Glioblastoma
26. RNase H–dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis
27. A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
28. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
29. Comprehensive genomic characterization of squamous cell lung cancers
30. Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
31. Data from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
32. Supplementary Figures Legends from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
33. Supplementary Tables from Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
34. Data from A Functional Screen Identifies miRs That Induce Radioresistance in Glioblastomas
35. Supplementary Tables 1-7 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
36. Supplementary Methods and Figures 1-5 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
37. Supplementary Table S7 from The Genomic Landscape of Pediatric Ewing Sarcoma
38. Data from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
39. Supplementary Tables 1-10 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
40. Supp. Table S22 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
41. Supplementary Methods, Figure Legends, Figures S1 - S6, Tables S1, S3 - S6, S8 - S15, S17 from The Genomic Landscape of Pediatric Ewing Sarcoma
42. Data from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
43. Supplementary Figures 1-13 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
44. Supplementary Figures and tables from A Functional Screen Identifies miRs That Induce Radioresistance in Glioblastomas
45. Supp. Tables S1, S3-S15, S20, and S23 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
46. Supplementary Methods, Figure Legends 1-13, Table Legends 1-10 from microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
47. Supp. Tables S16-S19 from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
48. Data from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
49. Supp. Figures and Legends from Genetic Mechanisms of Immune Evasion in Colorectal Cancer
50. Supplementary Figure from Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.